Chemotherapeutic agents

MedLecturesMadeEasy
3 Nov 201516:29

Summary

TLDRThis video script offers an insightful overview of chemotherapeutic agents used in cancer treatment. It covers various drug classes, including alkala agents, antimetabolites, microtubular targeting agents, topoisomerase inhibitors, anthracyclines, and monoclonal antibodies. Each class's mechanism of action and side effects are discussed, providing a comprehensive understanding of how these agents target cancer cells while minimizing harm to healthy cells.

Takeaways

  • 🔬 Chemotherapeutic agents are drugs used to treat cancer by interfering with the ability of cancer cells to grow and divide.
  • 🌿 Vinca alkaloids and taxanes are two classes of chemotherapeutic agents that affect microtubules, leading to cell death by disrupting cell division.
  • 🔄 Topoisomerase inhibitors, such as Topo I and Topo II, prevent the relaxation of supercoiled DNA, leading to cell death by inhibiting DNA replication.
  • 🧪 Alkylating agents, including both typical and atypical agents like platinum compounds, work by attaching to DNA, causing cross-linking and preventing replication.
  • 💊 Antimetabolites mimic normal cell compounds to inhibit DNA replication, with specific action during the S phase of the cell cycle.
  • 🌐 Microtubule targeting agents, like vinca alkaloids and taxanes, either destroy or stabilize microtubules, preventing their function and halting cell division.
  • 🩺 Monoclonal antibodies are engineered to target specific proteins or receptors on cancer cells, offering a more targeted approach to cancer treatment.
  • 💉 Anthracyclines have a complex mechanism of action, including intercalating DNA, inhibiting topoisomerase II, and generating reactive oxygen species.
  • 🩹 Side effects of chemotherapeutic agents can be severe, including myelosuppression, neuropathy, and organ toxicity, and vary depending on the class of the drug.
  • 🧬 Hormonal therapies, such as anti-estrogens for breast cancer and anti-androgens for prostate cancer, aim to block hormone production or activity to inhibit cancer growth.

Q & A

  • What are the two classes of chemotherapeutic agents that affect microtubules?

    -The two classes of chemotherapeutic agents that affect microtubules are Vinca alkaloids and Taxanes.

  • How do Alkylating agents damage DNA?

    -Alkylating agents damage DNA by attaching alkyl groups to DNA, usually between two base pairs, allowing for cross-linking of base pairs, which damages the DNA and makes it unable to replicate, leading to cell death.

  • What are the side effects commonly associated with Alkylating agents?

    -Common side effects of Alkylating agents include myelosuppression, nausea and vomiting, secondary malignancies, infertility, and hemorrhagic cystitis.

  • Which chemotherapeutic agent is known to be the strongest inducer of nausea and vomiting?

    -Cisplatin is known to be the strongest inducer of nausea and vomiting among the chemotherapeutic agents discussed.

  • How do antimetabolites inhibit DNA replication?

    -Antimetabolites inhibit DNA replication by mimicking normal cell compounds, thereby interfering with the normal process of DNA replication.

  • What are the three categories of antimetabolites mentioned in the script?

    -The three categories of antimetabolites mentioned are folate inhibitors, pyrimidine inhibitors, and purine analogs.

  • What is the primary side effect of Methotrexate, a folate inhibitor?

    -The primary side effect of Methotrexate is mucositis, along with myelosuppression.

  • How do microtubular targeting agents like Vinca alkaloids and Taxanes affect cancer cells?

    -Vinca alkaloids destroy microtubules, preventing their function, while Taxanes stabilize microtubules, both rendering them useless and inhibiting mitosis.

  • What are the side effects associated with Topoisomerase inhibitors?

    -Side effects associated with Topoisomerase inhibitors include myelosuppression, mucositis, and secondary malignancies such as acute myeloid leukemia.

  • What is the mechanism of action of Anthracyclines?

    -Anthracyclines have an ambiguous mechanism of action; they can intercalate DNA, inhibit topoisomerase II, generate reactive oxygen species, and cause alkylation.

  • What are the side effects of administering Anthracyclines?

    -Side effects of administering Anthracyclines include an increased risk of biventricular heart failure based on cumulative dose and tissue necrosis in case of extravasation.

Outlines

00:00

🔬 Chemotherapeutic Agents Overview

The script introduces various chemotherapeutic agents used in cancer treatment, focusing on their mechanisms of action and side effects. It discusses three main classes of drugs: alkala agents, antimetabolites, and microtubular targeting agents. Alkala agents, such as cyclophosphamide and cisplatin, work by attaching to DNA and causing cross-linking, which damages the DNA and leads to cell death. Antimetabolites inhibit DNA replication by mimicking normal cell compounds and are specific to cells in the S phase of the cell cycle. Microtubular targeting agents, like vinka alkaloids and taxanes, affect the mitotic spindle, preventing cell division. The script also mentions the importance of these agents being more effective at killing cancer cells than normal cells.

05:02

💊 Side Effects and Specific Agents

This section delves into the side effects associated with chemotherapeutic agents, such as myelosuppression, nausea, vomiting, and neuropathy. It also highlights specific agents within each class, including typical and atypical alkala agents, and their unique side effects. For instance, cisplatin is noted for its strong induction of nausea and vomiting, while atypical alkala agents like nitrosoureas can cause pulmonary toxicity and central nervous system problems. The script emphasizes the need for careful administration and the management of these side effects in cancer treatment.

10:02

🧬 DNA Interaction and Topoisomerase Inhibitors

The script explains how anthracyclines interact with DNA, potentially intercalating between strands, inhibiting topoisomerase 2, generating reactive oxygen species, and causing cross-linking between DNA base pairs. It also discusses topoisomerase inhibitors, which prevent the relaxation or recoiling of supercoiled DNA, leading to cell death. Specific drugs like topotecan and irinotecan are mentioned, along with their side effects, which include myelosuppression and diarrhea. The section also touches on the use of these drugs in combination regimens, such as the 7+3 chemotherapy plan.

15:03

🏥 Monoclonal Antibodies and Other Therapies

The final paragraph discusses monoclonal antibodies, which are synthesized to target specific receptors or factors that inhibit cancer growth. The script explains the origin of these antibodies based on their suffixes, indicating whether they are derived from mice, chimeric, humanized, or fully human. Examples include rituximab, which targets CD20 for lymphoma treatment, and bevacizumab, which targets vascular endothelial growth factor for solid tumors. The script also briefly mentions other chemotherapeutic agents like bleomycin, which causes lung toxicity, and hormonal therapies for breast and prostate cancer. The summary concludes with a note on the importance of understanding the mechanisms of action and side effects of these agents in chemotherapy.

Mindmap

Keywords

💡Chemotherapeutic Agents

Chemotherapeutic agents are drugs used to treat cancer by interfering with the growth and spread of cancer cells. They can be classified into various groups based on their mechanisms of action. In the video, several classes of chemotherapeutic agents are discussed, including alkala agents, antimetabolites, microtubular targeting agents, topoisomerase inhibitors, anthracyclines, and monoclonal antibodies, each with distinct mechanisms and side effects.

💡Alka Agents

Alka agents are a class of chemotherapeutic drugs that attach alkal groups to DNA, causing cross-linking between base pairs and preventing DNA replication, ultimately leading to cell death. The video mentions both typical and atypical alkala agents, such as cyclophosphamide, cisplatin, and the nitrosoureas, which have different side effects like myelosuppression, nephrotoxicity, and pulmonary toxicity.

💡Antimetabolites

Antimetabolites are a group of chemotherapeutic agents that inhibit DNA replication by mimicking normal cell compounds. They are specific to cells in the S phase of the cell cycle. Examples from the video include folate inhibitors like methotrexate, pyrimidine inhibitors like 5-fluorouracil, and purine analogs like 6-mercaptopurine, each with unique side effects such as mucositis and myelosuppression.

💡Microtubular Targeting Agents

Microtubular targeting agents interfere with the normal function of microtubules during cell division, leading to cell death. Vinca alkaloids, such as vincristine, destroy microtubules, while taxanes, like paclitaxel and docetaxel, stabilize them. Both actions prevent the microtubules from separating chromosomes, which is crucial for cell division. Side effects of these agents include peripheral neuropathy and myelosuppression.

💡Topoisomerase Inhibitors

Topoisomerase inhibitors are drugs that target enzymes called topoisomerases, which are involved in DNA replication and transcription. There are two types discussed in the video: topoisomerase I inhibitors, like topotecan and irinotecan, which prevent the relaxation of supercoiled DNA, and topoisomerase II inhibitors, like etoposide and teniposide, which inhibit the re-ligation of DNA strands after transcription. Side effects include myelosuppression and, in the case of irinotecan, severe diarrhea.

💡Anthracyclines

Anthracyclines are a class of antibiotics with a complex mechanism of action that includes intercalating DNA, inhibiting topoisomerase II, and generating reactive oxygen species. They are characterized by a 'rubisone' ending in their names, like doxorubicin. Side effects of anthracyclines include cardiotoxicity, which is dose-dependent, and the risk of extravasation injury if not administered properly.

💡Monoclonal Antibodies

Monoclonal antibodies are laboratory-produced molecules designed to target specific antigens on cancer cells. They can be derived from mice (omab), be chimeric (ximab), humanized (umab), or fully human (mumab). The video mentions several monoclonal antibodies, such as rituximab for B-cell lymphomas, trastuzumab for HER2-positive breast cancer, and bevacizumab for solid tumors, each with different side effects like hypersensitivity reactions and GI perforations.

💡Myelosuppression

Myelosuppression refers to the decrease in the production of blood cells in the bone marrow, often a side effect of chemotherapy. It can lead to anemia, neutropenia, and thrombocytopenia, increasing the risk of infections and bleeding. The video discusses myelosuppression as a common side effect of many chemotherapeutic agents, including alkala agents and antimetabolites.

💡Peripheral Neuropathy

Peripheral neuropathy is a type of nerve damage that affects the peripheral nervous system, causing symptoms like tingling, numbness, and pain in the hands and feet. It is a common side effect of certain chemotherapeutic agents, particularly microtubular targeting agents like vinca alkaloids and taxanes, as mentioned in the video.

💡Extravasation

Extravasation is the accidental leakage of a drug, especially a chemotherapeutic agent, into the surrounding tissue during administration. The video highlights the risk of anthracyclines causing tissue necrosis if they extravasate, which underscores the importance of careful administration by trained healthcare professionals.

💡Hormonal Therapies

Hormonal therapies are treatments that target hormone-sensitive cancers, such as breast and prostate cancers. The video discusses antiestrogens like tamoxifen for breast cancer and anti-androgens for prostate cancer, which work by blocking hormone production or action, thereby inhibiting cancer cell growth. These therapies can have specific side effects related to hormone imbalance.

Highlights

Vinka alkaloids and taxanes are chemotherapeutic agents that affect microtubules, playing a crucial role in cancer treatment.

Topoisomerase inhibitors can lead to cell death by preventing the relaxation of supercoiled DNA.

Chemotherapeutic agents aim to kill cancer cells more effectively than normal cells, ensuring minimal harm to healthy tissue.

Alkylating agents attach alkyl groups to DNA, causing cross-linking that damages DNA and leads to cell death.

Cyclophosphamide and ifosfamide are typical alkylating agents with various side effects, including myelosuppression and nausea.

Platinum compounds, such as cisplatin, work by cross-linking purine DNA bases and have side effects like nephrotoxicity.

Nitrosoureas, related to mustard gas, cause pulmonary toxicity and central nervous system problems.

Antimetabolites inhibit DNA replication by mimicking normal cell compounds and are specific to cells in the S phase.

Methotrexate, a folate inhibitor, is commonly used and requires leucovorin to protect healthy cells from its effects.

5-FU, a pyrimidine inhibitor, causes myelosuppression and GI problems depending on its administration method.

Capecitabine is an oral prodrug for 5-FU, and its side effect includes hand-foot syndrome.

Microtubular targeting agents, like vinca alkaloids, inhibit mitosis by destroying microtubules, preventing chromosome separation.

Taxanes stabilize microtubules, preventing their function and leading to cell death by disrupting chromosome separation.

Anthracyclines have a multifaceted mechanism of action, including intercalating DNA and generating reactive oxygen species.

Monoclonal antibodies are synthesized to target specific receptors known to inhibit cancer growth.

Rituximab targets CD20, commonly used to treat lymphomas, and is an example of a monoclonal antibody.

Bevacizumab targets VEGF and is used for solid tumors, with a side effect of GI perforation due to its mechanism of action.

Hormonal therapies, such as tamoxifen for breast cancer and anti-androgens for prostate cancer, target hormone production to inhibit cancer growth.

Transcripts

play00:02

this is a short video on

play00:03

chemotherapeutic agents we have a few

play00:06

scattered pictures and diagrams here to

play00:08

start on the left we have vinka alids

play00:11

and taxanes which are two classes that

play00:13

affect microtubules we'll talk about how

play00:15

those affect macrotubes and and the

play00:17

action of killing cancer we have in the

play00:20

middle the two Topo isomerase Inhibitors

play00:23

and we're going to talk about how those

play00:24

can lead to cell death as long as well

play00:26

as a couple examples of those and on the

play00:28

right here we have a general graph that

play00:30

shows how when we use chemotherapeutic

play00:32

agents we want to ensure that they kill

play00:34

cancer cells better than they kill

play00:36

normal cells so we're going to jump

play00:38

right into talking about the classes of

play00:40

these chemical agents used in the

play00:41

treatment of cancer this is

play00:43

chemotherapeutic

play00:44

Agents we're going to start with alkala

play00:47

agents first this is the first class

play00:48

we're going to be talking about now

play00:50

alkala agents in general attach alkal

play00:53

groups to DNA they usually attach groups

play00:55

between two base pairs allowing for

play00:57

cross-linking of base pairs this of

play00:59

course damages the DNA makes you unable

play01:01

to replicate it and it kills the cell

play01:04

that way now the good thing about

play01:05

ulating agents is that they they are not

play01:08

specific to any part of the cell cycle

play01:09

so they should be working on all cells

play01:11

regardless of what part of the cell

play01:13

cycle they're

play01:14

in we have some common typical alkala

play01:17

agents here we have typical and atypical

play01:20

alkala agents we're going to start

play01:21

talking about the typical ones the two

play01:23

that are that are important to know are

play01:24

cyclophosphamide and if phosphamide now

play01:28

there's a whole list of side effects

play01:29

with these and a lot of them are the

play01:30

ones that you might classically think of

play01:32

as side effects to chemotherapy we have

play01:34

Milos supression which means a drop in

play01:36

white blood cells a drop in hemoglobin

play01:38

and a drop in the crits we have nausea

play01:40

and vomiting that's the big one

play01:41

Everybody's scared of nausea and

play01:43

vomiting when getting chemo we have

play01:44

secondary malignancies we have

play01:46

infertility and hemorrhagic cystitis

play01:49

which is a problem with the kidneys you

play01:51

get blood in the urine and you have pain

play01:53

with urination um it's caused by the

play01:55

irritation of the bler from the acryline

play01:58

metabolite now we have atypical alkala

play02:00

agents as well we're going to start off

play02:02

by talking about the Platinum compounds

play02:04

these work by coal binding purine DNA

play02:07

bases we're going to talk about three of

play02:09

these first we have cisplatin which has

play02:11

side effects of nephrotoxicity and

play02:13

nausea and vomiting this is actually the

play02:15

strongest inducer of nausea and vomiting

play02:17

that we're going to be talking about

play02:18

today it's extremely poent potent and it

play02:21

it almost certainly causes vomiting in a

play02:23

patient if you don't give them any

play02:25

medication for for vomiting when you're

play02:27

administering cisplatin we have carop

play02:30

platin which causes platelet problems

play02:33

and we have oxop platin which causes

play02:35

cold sensitivity and it's worth

play02:37

mentioning that all of these Platinum

play02:38

compounds also cause peripheral

play02:40

neuropathies or like a like the pins and

play02:43

needles tingling in your in your fingers

play02:45

and fingers and toes next group of

play02:47

atypical alkala agents are the nitroso

play02:50

uras now these are two acronyms bcnu

play02:53

ccnu the actual names for these drugs

play02:56

have mus in them M like car musine it's

play03:00

because they are related to mustard gas

play03:03

that was used during one of the world

play03:04

wars so it's easy to remember that these

play03:07

which are related to mustard gas if you

play03:09

look up the full names of them cause

play03:10

pulmonary toxicity and it's also worth

play03:12

mentioning that they also cause fitis

play03:15

and central nervous system problems so

play03:18

these are the alkala agents next we're

play03:20

going to talk about antimetabolites we

play03:22

also have three categories of these but

play03:24

first antimetabolites inhibit DNA

play03:27

replication by mimicking normal cell

play03:30

compounds and because these are

play03:31

inhibiting DNA replication they are

play03:33

specific to cells that are in the S

play03:35

phase because you undergo DNA repli

play03:37

replication in the S

play03:39

phase first group we're going to talk

play03:40

about is folate Inhibitors and the big

play03:42

one here is methotraxate very commonly

play03:44

used drug it inhibits dihydrofolate

play03:47

reductase which is an enzyme that

play03:48

prevents the Regeneration of

play03:50

tetrahydrofolate and it inhibits the

play03:52

conversion of folate which is a dietary

play03:54

supplement something that we get from

play03:56

our food into

play03:58

tetrahydrofolate when when we administer

play04:00

Methotrexate we always want to do it

play04:02

with lucor lucor is an adant that

play04:05

protects the healthy cells it actually

play04:07

gives the healthy cells another method

play04:09

of getting folate another method of

play04:11

using folate and uh Methotrexate and

play04:14

lucor go together for that reason side

play04:17

effect of Methotrexate is mucositis and

play04:19

Milo supression Milo suppression is

play04:21

going to come up quite a bit next group

play04:23

of antimetabolites are the peridian

play04:25

Inhibitors big one here is 5fu five fluo

play04:29

urasil which inhibits the enzyme

play04:30

thymidilate

play04:33

synthetase when you administer 5fu as a

play04:35

Bolis it's going to cause Milo

play04:37

suppression if you administer it in a

play04:38

continual dose it's going to cause GI

play04:41

problems like diarrhea mucositis so the

play04:43

side effects of 5fu depend on how you

play04:46

administer it you also want to use lcav

play04:48

Orin with 5fu for a different reason

play04:50

this time this time lcav Orin helps the

play04:52

mechanism of action of 5fu when you use

play04:56

methotraxate and lucor lucor protects

play04:58

the healthy cells when you use 5fu and

play05:01

Lorin lucor potentiates the mechanism of

play05:05

action of 5fu it's worth noting the

play05:07

difference of lucor between its use in

play05:09

Methotrexate and five floro

play05:12

uracil Cape cabine is essentially an

play05:14

oral prodrug for 5fu now 5fu normally is

play05:19

not administered orally cap cadine is a

play05:21

pro drug which means that it must be

play05:23

further processed in the body before it

play05:25

becomes active and that's cap citadine

play05:28

one of the side effects of cap citadine

play05:29

is hand foot syndrome your palms and

play05:31

your feet become red they can start

play05:34

blistering and the last of the

play05:35

perimidine Inhibitors is

play05:37

cabine which is a rabinos c it's a DNA

play05:40

chain

play05:41

Terminator side effect here is

play05:43

conjunctivitis and cerebral neural

play05:45

defects so a or cabine causes

play05:49

conjunctivitis and cerebral defects so

play05:51

CCC a conjuntivitis cerebral neural

play05:56

defects it's also worth mentioning that

play05:58

cabine is the seven and seven plus

play06:00

chemotherapy if you haven't heard of

play06:02

that it's like a 10-day regimen of

play06:03

chemotherapy that's very common for the

play06:05

first seven days you're going to be

play06:06

administering cabine and that's before

play06:09

three days of anthracyclin we'll talk

play06:11

about anthracyclin in a

play06:12

second and there's one other class of

play06:15

antimetabolites called the purine analog

play06:18

and the one that is important to know is

play06:20

six mapto purine easy to remember that

play06:22

as a purine analog six

play06:24

mercaptopurine so we have three classes

play06:26

of antimetabolites which is a larger

play06:28

class of therapeutic drugs we have

play06:30

folate Inhibitors perimidine Inhibitors

play06:32

and purine

play06:34

analoges now another class microtubular

play06:37

targeting

play06:38

agents these drugs inhibit mitosis

play06:40

mitosis of course uh occurs during the

play06:44

mphase they uh specifically Target the

play06:47

microtubular activity during mitosis

play06:49

we're going to talk about how they do

play06:50

that vinka alids firstly destroy

play06:52

microtubules easy to remember vinka

play06:54

alids destroy microtubules and that

play06:57

obviously prevents their function three

play06:59

vinka alids are listed here blast is

play07:01

underlined you'll see why in a second

play07:03

side effects of vinka alids are

play07:05

peripheral neuropathy and Milo

play07:07

suppression blast is the strongest of

play07:10

the of those three in suppressing the uh

play07:13

the the immune system so BL Vin VIN

play07:15

blastin is the strongest Milos

play07:18

supressive chemotherapeutic drug it has

play07:19

the strongest side

play07:21

effect one important thing to remember

play07:23

about vinka alids is that you cannot

play07:25

inject them directly into the spine they

play07:27

are fatal if given intrathecally

play07:30

next group of microt tual targeting

play07:32

agents are the tanses these stabilized

play07:34

microtubules which prevent them from

play07:36

doing what they actually need to do

play07:38

which prevent the microtubules from

play07:39

actually touching the chromosomes and

play07:40

pulling them apart during metaphase so

play07:42

vinka alids destroy them tanes stabilize

play07:45

them both render them

play07:47

useless two Texans that are important to

play07:49

know were pexel and dosex side effect of

play07:52

these are mild suppression we're going

play07:53

to be seeing that a lot and peripheral

play07:56

neuropathies there's also hyper

play07:57

sensitivity associated with these and

play07:59

it's important to note that the hypers

play08:00

sensitivity doesn't come from the drugs

play08:02

doesn't come from pxel and doxal

play08:04

directly but rather it comes from the

play08:06

diluents that the drugs are dissolved in

play08:08

these diluents cremophor and tween80

play08:12

both cause hypers sensitivity the one

play08:14

from pcxl cremor is a little more

play08:17

potent if we don't want to deal with

play08:19

this hypers sensitivity we could also

play08:21

administer a braan which is a different

play08:24

formulation of pxel it's protein bound

play08:27

pxel and it helps us avoid hypers

play08:29

sensitivity that's involved with the

play08:31

cremor diluent in pet

play08:34

axel one of the trade-offs of using

play08:36

abraxane versus pet Axel is that you

play08:38

have more neuropathy so you have less

play08:40

hypers sensitivity but more

play08:43

neuropathy next class toois Inhibitors

play08:46

there's Topo isomerous one Topo isas 2

play08:49

the ones that inhibit Topo one prevent

play08:51

the relaxation of super coil DNA two of

play08:54

these to remember Topo tan and irin

play08:57

iroan iroan has a fun pneumonic to help

play09:01

you remember what it does we'll get in

play09:02

that in a second both of these cause myo

play09:04

suppression like almost everything else

play09:05

we're talking about iroan causes

play09:08

diarrhea e it remember because ireno

play09:10

Tean sounds like I ran to the can you

play09:12

ran to the can when you have diarrhea

play09:14

caused by

play09:15

aroan Topo 2 inhibitors prevent

play09:18

recoiling of DNA after transcription

play09:21

couple of these to remember are toide

play09:22

and teniposide both ending in ide Topo

play09:25

isas two Inhibitors both have side

play09:28

effects of M suppression mucositis and

play09:30

secondary malignancies such as causing

play09:33

AML acute acute myoblast leukemia these

play09:37

are the three fourm that are associated

play09:39

with topo2 Inhibitors such as etoposide

play09:42

and teniposide

play09:44

next class that we want to talk about

play09:46

are the

play09:47

anthracyclines anthracyclines kind of

play09:49

have an ambiguous mechanism of action

play09:51

they do a bunch of stuff they could do

play09:52

more than one of these they could just

play09:53

do a few of these some of them are

play09:55

listed here they can intercalate DNA

play09:57

which means that they insert themselves

play09:59

between the actual the two actual

play10:01

strands of DNA preventing their

play10:04

replication and preventing synthesis of

play10:06

RNA from that DNA so they intercalate

play10:08

DNA and just inhibit the use of that DNA

play10:10

they can also inhibit too isomerase 2

play10:12

one of them do rubinson uh in particular

play10:15

inhibits do or inhibits topoisomerase 2

play10:18

they can generate reactive oxygen

play10:20

species that cause oxidative damage to

play10:22

the DNA and they also might cause alkal

play10:25

which like we saw with the alkala agents

play10:28

can cause cross-linking between DNA

play10:29

based Pairs and uh and essentially

play10:32

render the DNA useless kind of like

play10:33

intercol of DNA anthocyans are easy to

play10:36

remember because they all end in rubison

play10:39

these are the rubinson dxor rubinson

play10:41

Donar rubison you can read the rest

play10:42

there Ida rubenson and EP rubison side

play10:46

effects of these are pretty common to

play10:48

all of them B ventricular heart failure

play10:50

and this is based on the dose the

play10:53

cumulative dose of the rubison

play10:55

administered so there's like a limit for

play10:57

each of these Rubin so Dr ubon's limit

play10:59

might be some number you can only give a

play11:01

person so much doxy rubenson before they

play11:03

hit that number and be at a

play11:05

statistically significant increase risk

play11:07

for biventricular heart failure one

play11:10

other side effect for the anthocyans is

play11:12

that they are necrotic with extrav this

play11:15

means that if you when you're normally

play11:17

injecting these into the veins if you

play11:19

miss the veins and accidentally get some

play11:21

of these anthy into the surrounding

play11:23

tissue they can cause necrosis of that

play11:25

tissue leave very nasty looking wounds

play11:27

they could tear up somebody's whole arm

play11:29

tear up somebody's wrist if you miss

play11:31

when inserting a vein so nurses are

play11:33

trained really well to to be very

play11:34

careful about administering anthres if

play11:37

you want to look up some pictures of

play11:38

this it looks pretty nasty it's kind of

play11:39

fun to look at uh you can you can look

play11:41

up anthy extravasion and it should be

play11:44

pretty easy to

play11:46

find it's also worth noting that

play11:48

anthocyans are the three in the

play11:50

aforementioned 7 plus three chemotherapy

play11:52

so you have seven days of cabine

play11:55

followed by three days of one of the

play11:57

anthocyans such as duct

play12:00

rubenson next class are the monoclonal

play12:02

antibodies these are antibodies that are

play12:04

synthesized to a specific Target that

play12:07

has been known to inhibit cancer we'll

play12:09

give you a bit more detail here the

play12:11

origin of the monocolonal antibodies can

play12:13

be determined from the suffixes so monal

play12:16

antibodies ending in omab Come From Mice

play12:18

or Mouse is easier to remember the O

play12:20

from omab o from

play12:23

Mouse the xab ending or imab uh comes

play12:28

from the

play12:30

chimeric antibodies these chimeric

play12:33

antibodies are a cross between human and

play12:35

mouse so they have some human in them

play12:38

this list by the way is is in decreasing

play12:40

order of how much mice is involved in

play12:43

these antibodies so this umab this next

play12:45

one is humanized which means it's about

play12:48

10% Mouse 90% human easy to remember

play12:51

because umab has a u in it just like

play12:54

human then finally the fully human

play12:57

antibodies are called mumab now these

play12:59

mums are 100% human so I believe the the

play13:02

chimeric antibodies are about 33% human

play13:05

the humanized antibodies are about 10%

play13:07

human and the fully human antibodies

play13:09

excuse me the umab antibodies are about

play13:11

10% Mouse and the fully human antibodies

play13:14

are about 0%

play13:18

Mouse we have a list of four important

play13:21

monoclonal antibodies that are that are

play13:23

probably worth knowing uh start with

play13:26

rmab very commonly used it targets cd2

play13:29

which is a receptor very common to B

play13:32

cells it's used to treat lymphomas or

play13:34

the abnormal proliferation of B cells

play13:36

that you often see in lymphomas and

play13:38

we're not going to we're not going to be

play13:39

discussing the toxicity for the first

play13:40

two but Target cd20 used for

play13:43

lymphomas there's another one used for

play13:45

breast cancer targets her too also not

play13:48

as not as significant camab targets the

play13:51

egfr receptor andth thelial growth

play13:55

factor receptor this is uh used to treat

play13:58

solid tumor and it was initially

play14:00

developed to treat color rectal cancer

play14:02

one of the side effects of camab is that

play14:05

you get hypers sensitivity in the form

play14:06

of an acneform rash so it looks like you

play14:09

have dots all over your skin you get a

play14:11

rash if you use camab another one that's

play14:14

worth knowing is Bez

play14:16

bevacizumab which targets VF which is a

play14:19

vascular endothelial growth factor also

play14:21

used for solid tumors um initially

play14:24

developed for coloral and lung cancers

play14:26

this is a problem because it can cause G

play14:28

ey perforation VF is a factor that

play14:32

promotes angiogenesis promotes the

play14:34

growth of of blood vessels into new

play14:37

parts of the body or into tumors if you

play14:39

inhibit those you can weaken the GI

play14:42

tract and cause perforation of the GI

play14:46

tract and finally we're going to have a

play14:48

short list of other chemotherapeutic

play14:50

agents bomy is worth noting because it

play14:53

causes lung toxicity just like the the

play14:56

ones related to mustard gas that we

play14:57

talked about earlier the nitroso uras

play15:00

bomy also causes long

play15:02

toxicity side effects of this long

play15:04

toxicity include pulmonary fibrosis

play15:07

interstial pneumonitis and hypers

play15:10

sensitivity pneumonitis which includes

play15:12

cough for having infiltrates in the

play15:15

lungs and there are a couple other

play15:17

hormonal therapies that are worth

play15:19

knowing some of these are for breast

play15:21

cancer specifically the

play15:23

antiestrogens such as tamoxifen and the

play15:26

aromatase inhibitor

play15:29

rheumatism I don't think I have any

play15:30

examples here but they block the

play15:31

synthesis of estrogen actually there are

play15:33

a couple examples ending in OZO so the

play15:36

one that's important to know is the

play15:37

anti-estrogen

play15:39

tamoxifen there are also some hormonal

play15:41

therapies for prostate cancer such as

play15:43

the anti-androgens and there should be a

play15:46

small list of these like the LH RH

play15:48

antagonists or excuse me lhrh agonists

play15:51

the GnRH antagonists and the cyp17

play15:55

Inhibitors and if you look up the

play15:56

production of testosterone you can kind

play15:58

of see how these three subclasses of

play16:01

anti-androgens all kind of inhibit

play16:03

testosterone production in a different

play16:04

way all with the evental goal of

play16:07

preventing Androgen stimulation of

play16:10

prostate cancer so these are other

play16:12

chemotherapeutic agents that didn't

play16:13

really fit into the other categories

play16:15

this has been a brief review of

play16:17

chemotherapy agents I hope it was

play16:19

helpful and I hope it was uh good a good

play16:22

introduction to to commonly use drugs

play16:24

and their mechanisms of actions and side

play16:26

effects thanks for listening

Rate This

5.0 / 5 (0 votes)

Связанные теги
Cancer TreatmentChemotherapy AgentsDrug MechanismsSide EffectsMedical EducationHealthcare ProfessionalsPharmacologyCancer DrugsTherapeutic AgentsMedical Review
Вам нужно краткое изложение на английском?